The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
- Investigator
- Justin D Hilliard
- Ages
- 50 Years - 85 Years
- Sexes
- All